ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JULIO LOPEZ ANDUJAR MD

4410 W 16TH AVENUE CAC FLORIDA

Hialeah | Florida | 33012

(305) 827-2002

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,217Medicare Part D Prescriptions Filled, Including Refills

Rank: 291 out of 3647

$329K Total Retail Price of All Prescriptions

Rank: 1840 out of 3647

599 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 17,533 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$18 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,897 1,830 1 1
OMEPRAZOLE 1,364 1,322 2 3
LISINOPRIL 1,323 1,245 3 4
LEVOTHYROXINE SODIUM 1,043 993 4 5
AMLODIPINE BESYLATE 861 831 5 2
ATORVASTATIN CALCIUM 856 815 6 13
LOSARTAN POTASSIUM 666 664 7 11
HYDROCHLOROTHIAZIDE 609 584 8 9
GLYBURIDE 542 537 R 9 54
ATENOLOL 502 478 10 10
METFORMIN HCL 455 423 11 6
METOPROLOL SUCCINATE 393 387 12 18
METOPROLOL TARTRATE 364 346 13 7
RANITIDINE HCL 307 307 14 29
WARFARIN SODIUM 275 261 15 15
PANTOPRAZOLE SODIUM 257 241 16 38
FUROSEMIDE 254 220 17 8
ALENDRONATE SODIUM 227 222 18 23
VIAGRA 220 215 19 69
ISOSORBIDE MONONITRATE ER 198 198 20 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 193 193 21 36
CARVEDILOL 192 192 22 20
LOSARTAN-HYDROCHLOROTHIAZIDE 190 190 23 48
DIGOXIN 172 164 24 51
ENALAPRIL MALEATE 172 168 24 35
POTASSIUM CHLORIDE 143 118 26 24
GABAPENTIN 139 138 27 17
GLIPIZIDE 135 134 28 41
DOXAZOSIN MESYLATE 125 125 29 57
NIFEDIPINE ER 124 119 30 67
PAROXETINE HCL 116 116 31 60
CRESTOR 116 112 31 19
VENTOLIN HFA 113 105 33 88
FENOFIBRATE 111 106 34 50
MECLIZINE HCL 109 109 35 85
FELODIPINE ER 109 109 35 186
TERAZOSIN HCL 105 99 37 103
TRIAMTERENE-HCTZ 102 102 38 58
SYNTHROID 98 98 39 42
VERAPAMIL ER 97 97 40 99
CLOPIDOGREL 91 86 41 26
AMLODIPINE BESYLATE-BENAZEPRIL 88 87 42 74
ZOSTAVAX 86 85 43 178
ZETIA 81 69 44 96
BENAZEPRIL HCL 80 80 45 71
LOVASTATIN 77 77 46 21
ALPRAZOLAM 73 73 47 31
ZOLPIDEM TARTRATE 72 72 48 14
GLIMEPIRIDE 67 58 49 45
GLIPIZIDE ER 65 45 50 112
METFORMIN HCL ER 64 62 51 92
FINASTERIDE 60 60 52 66
ALLOPURINOL 60 57 52 37
BISOPROLOL-HYDROCHLOROTHIAZIDE 57 57 54 183
LACTULOSE 54 54 55 128
BENICAR 50 50 56 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.